RS Oncology presents new drug in early clinical development for Mesothelioma and lung cancer patients
Start-up US biotech company tackling rare diseases presents three case studies in France
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
04 Aug 23
Start-up US biotech company tackling rare diseases presents three case studies in France
04 Aug 23
Increased manufacturing capacity combined with an expansion from 69 to 92 eligible countries, is expected to enable delivery…
03 Aug 23
The patent provides protection of the enema formulation of cobitolimod, that is currently under evaluation in the ongoing…
PharmaceuticalsActive Pharmaceutical Ingredients and Intermediates
03 Aug 23
The three-year agreement includes a joint request to dismiss with prejudice the pending litigation between the companies, including…
02 Aug 23
LX2020 is an AAV-based gene therapy that works by intravenously delivering a functional PKP2 gene to increase the…
02 Aug 23
Neuraxpharm’s dedicated neurology focus and established European presence makes them an attractive partner for BRIUMVI’s European launch, targeted…
02 Aug 23
Phase 2 study initiated at clinical sites in Australia with monovalent and bivalent mRNA COVID-19 vaccine candidates
01 Aug 23
The combination of Jemperli and chemotherapy consisting of carboplatin and paclitaxel has been indicated for patients having primary…
01 Aug 23
The acquisition supports BioNTech's strategy to establish capabilities for artificial intelligence (AI)-driven drug discovery and create next-generation immunotherapies…
01 Aug 23
The primary objective of the cOLE study is to assess the efficacy and safety of extended and repeated…